Literature DB >> 25447551

May the remodeling of the Ca²⁺ toolkit in endothelial progenitor cells derived from cancer patients suggest alternative targets for anti-angiogenic treatment?

Francesco Moccia1, Valentina Poletto2.   

Abstract

Endothelial progenitor cells (EPCs) may be recruited from bone marrow to sustain the metastatic switch in a number of solid cancers, including breast cancer (BC) and renal cellular carcinoma (RCC). Preventing EPC mobilization causes tumor shrinkage. Novel anti-angiogenic treatments have been introduced in therapy to inhibit VEGFR-2 signaling; unfortunately, these drugs blocked tumor angiogenesis in pre-clinical murine models, but resulted far less effective in human patients. Understanding the molecular mechanisms driving EPC proliferation and tubulogenesis in cancer patients could outline novel targets for alternative anti-angiogenic treatments. Store-operated Ca²⁺ entry (SOCE) regulates the growth of human EPCs, and it is mediated by the interaction between the endoplasmic reticulum Ca²⁺-sensor, Stim1, and the plasmalemmal Ca²⁺ channels, Orai1 and TRPC1. EPCs do not belong to the neoplastic clone: thus, unlike tumor endothelium and neoplastic cells, they should not remodel their Ca²⁺ toolkit in response to tumor microenvironment. However, our recent work demonstrated that EPCs isolated from naïve RCC patients (RCC-EPCs) undergo a dramatic remodeling of their Ca²⁺ toolkit by displaying a remarkable drop in the endoplasmic reticulum Ca²⁺ content, by down-regulating the expression of inositol-1,4,5-receptors (InsP3Rs), and by up-regulating Stim1, Orai1 and TRPC1. Moreover, EPCs are dramatically less sensitive to VEGF stimulation both in terms of Ca²⁺ signaling and of gene expression when isolated from tumor patients. Conversely, the pharmacological abolition of SOCE suppresses proliferation in these cells. These results question the suitability of VEGFR-2 as a therapeutically relevant target for anti-angiogenic treatments and hint at Orai1 and TRPC1 as more promising alternatives. This article is part of a Special Issue entitled: 13th European Symposium on Calcium.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Endothelial progenitor cel; Orai1; Stim1; TRPC1; Tumor vascularization; Vascular endothelial growth facto

Mesh:

Substances:

Year:  2014        PMID: 25447551     DOI: 10.1016/j.bbamcr.2014.10.024

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  14 in total

Review 1.  Crosstalk between calcium and reactive oxygen species signaling in cancer.

Authors:  Nadine Hempel; Mohamed Trebak
Journal:  Cell Calcium       Date:  2017-01-18       Impact factor: 6.817

2.  Influence of buffy coat-derived putative endothelial progenitor cells on tumor growth and neovascularization in oral squamous cell carcinoma xenografts.

Authors:  Marius Otto; Sebastian Blatt; Andreas Pabst; Robert Mandic; Johanna Schwarz; Andreas Neff; Thomas Ziebart
Journal:  Clin Oral Investig       Date:  2019-01-28       Impact factor: 3.573

Review 3.  STIM and Orai proteins as novel targets for cancer therapy. A Review in the Theme: Cell and Molecular Processes in Cancer Metastasis.

Authors:  Ayushi Vashisht; Mohamed Trebak; Rajender K Motiani
Journal:  Am J Physiol Cell Physiol       Date:  2015-05-27       Impact factor: 4.249

4.  Significance of endothelial progenitor cells (EPC) for tumorigenesis of head and neck squamous cell carcinoma (HNSCC): possible marker of tumor progression and neovascularization?

Authors:  Thomas Ziebart; Sebastian Blatt; Christian Günther; Nadine Völxen; Andreas Pabst; Keyvan Sagheb; Sebastian Kühl; Thomas Lambrecht
Journal:  Clin Oral Investig       Date:  2016-03-19       Impact factor: 3.573

Review 5.  Endothelial progenitor cells support tumour growth and metastatisation: implications for the resistance to anti-angiogenic therapy.

Authors:  Francesco Moccia; Estella Zuccolo; Valentina Poletto; Mariapia Cinelli; Elisa Bonetti; Germano Guerra; Vittorio Rosti
Journal:  Tumour Biol       Date:  2015-08-02

Review 6.  "Decoding" Angiogenesis: New Facets Controlling Endothelial Cell Behavior.

Authors:  Raj Sewduth; Massimo M Santoro
Journal:  Front Physiol       Date:  2016-07-21       Impact factor: 4.566

7.  VEGF-induced intracellular Ca2+ oscillations are down-regulated and do not stimulate angiogenesis in breast cancer-derived endothelial colony forming cells.

Authors:  Francesco Lodola; Umberto Laforenza; Fabio Cattaneo; Federico Alessandro Ruffinatti; Valentina Poletto; Margherita Massa; Richard Tancredi; Estella Zuccolo; Dlzar Alì Khdar; Alberto Riccardi; Marco Biggiogera; Vittorio Rosti; Germano Guerra; Francesco Moccia
Journal:  Oncotarget       Date:  2017-08-14

Review 8.  Endothelial Ca2+ Signaling and the Resistance to Anticancer Treatments: Partners in Crime.

Authors:  Francesco Moccia
Journal:  Int J Mol Sci       Date:  2018-01-11       Impact factor: 5.923

Review 9.  Store Operated Calcium Entry in Cell Migration and Cancer Metastasis.

Authors:  Ayat S Hammad; Khaled Machaca
Journal:  Cells       Date:  2021-05-19       Impact factor: 6.600

Review 10.  Ion Channel Profiling in Prostate Cancer: Toward Cell Population-Specific Screening.

Authors:  Valerio Farfariello; Natalia Prevarskaya; Dimitra Gkika
Journal:  Rev Physiol Biochem Pharmacol       Date:  2021       Impact factor: 5.545

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.